Shareholder plans sale of 13,500 common shares

A stockholder has filed a notice of intent to sell 13,500 shares of common stock, with an aggregate market value of $70,574, through broker Stifel Nicolaus & Company Inc. on or around 01/21/2026 on the Nasdaq exchange.

Rhea-AI Filing Summary

A stockholder has filed a notice of intent to sell 13,500 shares of common stock, with an aggregate market value of $70,574, through broker Stifel Nicolaus & Company Inc. on or around 01/21/2026 on the Nasdaq exchange. These shares were acquired from the issuer on 07/08/2025 as restricted stock units granted as equity compensation, and became payable in shares on the same date.

Over the past three months, the person for whose account the securities are to be sold has already sold 15,000 shares of common stock, generating $71,168 in gross proceeds. By signing the notice, the seller represents that they are not aware of any material adverse, nonpublic information about the issuer’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ABEO shares are planned to be sold under this Form 144?

The notice covers an intended sale of 13,500 shares of common stock, with an aggregate market value of $70,574, to be sold through Stifel Nicolaus & Company Inc. on the Nasdaq exchange.

When were the ABEO shares to be sold under this Form 144 acquired?

The 13,500 shares to be sold were acquired on 07/08/2025 as restricted stock units from the issuer, designated as equity compensation with the same date of payment.

How many ABEO shares are outstanding according to this filing?

The filing states that there are 54,191,361 shares of common stock outstanding at the time of the planned sale, providing a baseline for the size of the potential sale.

What ABEO share sales occurred in the last three months before this notice?

During the past three months, 15,000 shares of common stock were sold for $71,168 in gross proceeds by the person for whose account the current securities are to be sold.

Which broker and exchange are involved in this planned ABEO share sale?

The planned sale will be executed through Stifel Nicolaus & Company Inc., with the shares to be sold on the Nasdaq securities exchange.

What representation does the seller make about ABEO in this Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 01/21/2026 - 04:10 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001356828
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ABEONA THERAPEUTICS INC.
SEC File Number	001-15771
Address of Issuer	6555 CARNEGIE AVE, 4TH FLOOR CLEVELAND OHIO 44103
Phone	646-813-4701
Name of Person for Whose Account the Securities are To Be Sold	Alvino Mark
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	13500	70574.00	54191361	01/21/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/08/2025	Restricted Stock Units	Issuer			13500	07/08/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Mark Alvino 6555 Carnegie Ave Fl 4 Cleveland OH 44103	Common Stock	11/13/2025	15000	71168.00

144: Remarks and Signature

Remarks
Date of Notice	01/21/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Luca Lotito, as a duly authorized representative of STIFEL, as attorney-in-fact for Mark Alvino
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)